Medlander Medical Technology Inc.

Medlander Medical Technology Inc. is a prominent player in the pelvic health and comprehensive rehabilitation sector, with a strong foothold in the domestic market, boasting a 40% market share and an annual turnover exceeding $53 million. The company has established itself as a leading medical device provider, specializing in Biofeedback and Stimulation Systems, Pelvic Floor Magnetic Stimulation Systems, Ultrasonic Therapy Devices, In-home Training devices, and Sports Rehabilitation systems, catering to critical applications in Obstetrics, Gynecology, and Urology departments. Founded in 2013 and headquartered in China, Medlander has positioned itself as a key innovator in the industry by heavily investing in its R&D team, allowing the company to maintain full control over its design and production processes through its "in-house development, self-supply" business model. Notably, the company received a CNY10.00M Series A investment from Greenwoods Asset Management in December 2019, indicating strong investor confidence in its growth potential. With its commitment to advancing medical technology and its solid market presence, Medlander raises intrigue for potential venture capital opportunities, especially as it continues to drive technological innovation and expand its market reach, aligning with the evolving landscape of the health care industry. For more information, visit Medlander's website or reach out via email at [email protected].